Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02090114
Title RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistant (The RESTORE Study)
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

prostate adenocarcinoma

Therapies

Testosterone

Abiraterone

Enzalutamide

Age Groups: adult
Covered Countries USA


No variant requirements are available.